Delving into the Latest Updates on HEC137076MsOH with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Nervous System Diseases

Active Indication-

Inactive Indication

Migraine Disorders

Originator Organization

Sunshine Lake Pharma Co., Ltd.

Active Organization-

Inactive Organization

Sunshine Lake Pharma Co., Ltd.

License Organization-

Drug Highest PhasePendingPhase 1

First Approval Date-

Regulation-

Login to view timeline

[Translation] A single-center, randomized, double-blind, placebo-controlled, dose-escalation safety, tolerability, and pharmacokinetic trial of single/multiple oral administration of HEC137076MsOH tablets and a single-center, randomized, double-blind, two-period, two-sequence crossover food effect trial in healthy Chinese subjects

主要目的：评价HEC137076MsOH片在中国健康受试者中单次/多次口服给药的安全性和耐受性。次要目的：评价HEC137076MsOH片在中国健康受试者中单次/多次口服给药的药代动力学特征；评价食物对HEC137076MsOH片药代动力学的影响；评价HEC137076MsOH片在人体内的药物代谢转化。

[Translation]

Primary objective: To evaluate the safety and tolerability of HEC137076MsOH tablets after single/multiple oral administration in healthy Chinese subjects. Secondary objectives: To evaluate the pharmacokinetic characteristics of HEC137076MsOH tablets after single/multiple oral administration in healthy Chinese subjects; To evaluate the effect of food on the pharmacokinetics of HEC137076MsOH tablets; To evaluate the drug metabolism transformation of HEC137076MsOH tablets in humans.

Start Date15 Aug 2022

Sponsor / Collaborator

Sunshine Lake Pharma Co., Ltd.

100 Clinical Results associated with HEC137076MsOH

Login to view more data

100 Translational Medicine associated with HEC137076MsOH

Login to view more data

100 Patents (Medical) associated with HEC137076MsOH

Login to view more data

100 Deals associated with HEC137076MsOH

Login to view more data